Sign inJoin waitlistJoin the waitlist

Edda Spiekerkoetter

Director, HHT Center of Excellence · Stanford Health Care

Credentials: · · ·

History

HHT Center of Excellence · Stanford Health Care
Present
Stanford Health Care
Present
Stanford Health Care
Present

Stanford University Pulmonary and Critical Care Fellowship (2009) CA
2008–2009
Stanford University
2006–2008
Lucile Salter Packard Children's Hospital at Stanford
2003–2006
University of Freiburg
University of Freiburg
1991–1995
University Hospital Freiburg (1995) Germany
1992–1995

Research

Long-term treatment of primary pulmonary hypertension with aerosolized iloprost, a prostacyclin analogue
New England Journal of Medicine · 2000 · 394 citations
FK506 activates BMPR2, rescues endothelial dysfunction, and reverses pulmonary hypertension
Journal of Clinical Investigation · 2013 · First of 21 authors · 361 citations
Goal-oriented treatment and combination therapy for pulmonary arterial hypertension
European Respiratory Journal · 2005 · 345 citations

Marlene Rabinovitch
19 papers
Roham Zamanian
18 papers
Kenzo Ichimura
16 papers · 8 as a resident
Adam Andruska
12 papers · 3 as a fellow
Vinicio Perez
12 papers
Mark Nicolls
11 papers
Vitaly Kheyfets
9 papers
Francois Haddad
8 papers
Sushma Reddy
7 papers
Yon Sung
7 papers
Kristina Kudelko
6 papers
Kurt Stenmark
5 papers

Grants

Understanding and Targeting Molecular and Cellular Events Responsible for Pulmonary Arteriovenous Malformation Development, Growth and Regression
National Heart, Lung, and Blood Institute · R01
Contact PI · $2.8M · Stanford University
2023–2027
Understanding and Targeting Molecular as Well as Structural Events Governing Right Ventricular Adaptation, Failure and Recovery in Pulmonary Hypertension Using Repurposed Drugs
National Heart, Lung, and Blood Institute · R01
Contact PI · $1.7M · Stanford University
2021–2025
Vasculata 2024
National Heart, Lung, and Blood Institute · R13
Contact PI · $34.5K · Stanford University
2024–2025
Targeting Novel BMPR2 Modifiers in Pulmonary Hypertension with Repurposed Drugs
National Heart, Lung, and Blood Institute · R01
Contact PI · $2.1M · Stanford University
2016–2021

Clinical trials

FK506 (Tacrolimus) in Pulmonary Arterial Hypertension
Principal investigator · Completed · Phase 2
Edda Spiekerkoetter
2012–2014